Vaxart, Inc. Gains 30.16%
Tue, Jun 18, 2024 at 07:09 PM
Vaxart, Inc. (VXRT:NASDAQ) jumped higher at $0.68, a gain of 30.2%. The stock appeared on our News Catalysts scanner on Mon, Jun 17, 2024 at 06:49 PM in the 'INVESTOR UPDATE' category. From Tue, Jun 04, 2024, the stock recorded 30.00% Up Days and 18.18% Green Days
The stock spiked on Thu, Feb 22, 2024 at $1.54 with a volume of 4M+.
About Vaxart, Inc. (VXRT:NASDAQ)
Aviragen Therapeutics Inc is a bio-pharmaceutical company. It is engaged in developing direct-acting antivirals to treat infections that affect a number of patients. It includes oral, small molecule compounds to treat infectious diseases.
Top 10 Gainers:
- Comtech Telecommunications Corp. (CMTL:NASDAQ), 87.56%
- NLS Pharmaceutics Ltd. (NLSP:NASDAQ), 82.13%
- La Rosa Holdings Corp. (LRHC:NASDAQ), 72.12%
- Unico American Corporation (UNAM:NASDAQ), 50%
- Mesa Air Group, Inc. (MESA:NASDAQ), 39.82%
- Nexalin Technology Inc. (NXL:NASDAQ), 37.77%
- Dominion Energy Midstream Partners, LP (DM:NYSE), 35.79%
- Vaxart, Inc. (VXRT:NASDAQ), 30.16%
- ShiftPixy, Inc. (PIXY:NASDAQ), 27.27%
- Professional Diversity Network, Inc. (IPDN:NASDAQ), 27.12%